Introduction {#s1}
============

Inositol 1,4,5-trisphosphate receptors (IP~3~R) are intracellular Ca^2+^ channels that are expressed in almost all animal cells. They allow release of Ca^2+^ from intracellular stores in response to the many stimuli that activate phospholipase C [@pone.0058027-Foskett1], [@pone.0058027-Taylor1]. The genomes of vertebrates encode three closely related IP~3~R subtypes (IP~3~R1-3), and most cells from vertebrates express functional IP~3~R that are homo- or hetero-tetrameric assemblies of these IP~3~R subtypes and their splice variants [@pone.0058027-Taylor2]. The physiological significance of this IP~3~R diversity is poorly understood, and nor are there ligands that usefully discriminate between IP~3~R subtypes. It is, however, clear that activation of IP~3~R is initiated by binding of IP~3~ to the conserved IP~3~-binding core (IBC, residues 224-604 of IP~3~R1) of each IP~3~R subunit [@pone.0058027-Seo1]. Mixed populations of IP~3~R in native cells make it difficult to define unambiguously the functional properties of each IP~3~R subtype. Stable heterologous expression of mammalian IP~3~R in the only vertebrate cell line engineered to lack all endogenous IP~3~R (DT40 KO cells) [@pone.0058027-Sugawara1] provides an effective means of addressing this difficulty [@pone.0058027-Taylor3]. We previously used DT40 cells expressing homogeneous populations of each mammalian IP~3~R subtype to define structure-activity relationships for key endogenous and synthetic inositol phosphates [@pone.0058027-Saleem1]. Here, we extend the approach to examine the interactions of each IP~3~R subtype with adenophostin A (**1**, AdA) and its most important analogues [@pone.0058027-Rossi1] ([Figure 1A](#pone-0058027-g001){ref-type="fig"}).

![Structures of the analogues of AdA used.\
(A) Key moieties within IP~3~ and AdA are highlighted in matching colours to indicate their proposed structural equivalence. (B and C). The Ca^2+^ contents of the intracellular stores of populations of permeabilized DT40-IP~3~R1 cells are shown after addition of ATP to allow active Ca^2+^ uptake, and then addition of the indicated concentrations of IP~3~ or AdA with thapsigargin (1 µM) to inhibit further Ca^2+^ uptake. The traces, which are typical of those from all subsequent analyses, show the average response from 2 wells on a single plate. The results demonstrate that both IP~3~ and AdA evoke quantal Ca^2+^ release.](pone.0058027.g001){#pone-0058027-g001}

AdA, originally isolated from *Penicillium brevicompactum* [@pone.0058027-Takahashi1], [@pone.0058027-Takahashi2] and later synthesized [@pone.0058027-Hotoda1], is a potent agonist of IP~3~R. It is also resistant to degradation by the enzymes that degrade IP~3~ via phosphorylation or dephosphorylation [@pone.0058027-Takahashi2]. Although AdA is based on a glucose ring, rather than the inositol ring of IP~3~, its structure retains the key functional groups of IP~3~ that are known to be essential for IP~3~ activity at IP~3~R [@pone.0058027-Rossi2] ([Figure 1A](#pone-0058027-g001){ref-type="fig"}). Considerable evidence supports the original suggestion [@pone.0058027-Takahashi2] that the essential 4,5-bisphosphate and 6-hydroxyl of IP~3~ are effectively mimicked by the 4″,3″-bisphosphate and 2″-hydroxyl of AdA (red highlights in [Figure 1A](#pone-0058027-g001){ref-type="fig"}). The interactions that allow AdA to bind to IP~3~R with about 10-fold greater affinity than IP~3~ have been more difficult to resolve. One view was that the 2′-phosphate of AdA is equivalent to the 1-phosphate of IP~3~ and, like the latter [@pone.0058027-Wilcox1] (blue in [Figure 1A](#pone-0058027-g001){ref-type="fig"}), contributes to high-affinity binding to the IBC. The suggestion was that the 2′-phosphate of AdA forms a stronger interaction with the IBC than does the 1-phosphate of IP~3~. Our recent analyses have challenged this idea and instead suggest that a cation-π interaction between the adenine ring of AdA and a guanidinium side chain of an arginine residue within the α-domain of the IBC (R504 in IP~3~R1) may be a more important determinant of the increased affinity of AdA for IP~3~R [@pone.0058027-Rossi2].

The high-affinity and metabolic stability of AdA have generated considerable interest in both the synthesis of AdA analogues and their application to analyses of IP~3~R activation and associated changes in cytosolic Ca^2+^ signalling [@pone.0058027-Rossi2]. There has, however, been no systematic analysis of the activities of AdA or its analogues with defined populations of homogenous IP~3~R subtypes. The need for such analyses is particularly important in attempting to explain results in which Ca^2+^ signals evoked by IP~3~ differ from those evoked by AdA [@pone.0058027-Marchant1], [@pone.0058027-Mak1], [@pone.0058027-Bird1], [@pone.0058027-DeLisle1], [@pone.0058027-Gregory1], [@pone.0058027-Hartzell1], [@pone.0058027-Huang1], [@pone.0058027-Machaca1], or where different analogues of AdA evoke different cellular responses \[reviewed in 12,22\]. Here we use DT40 cells in which all endogenous IP~3~R have been genetically inactivated [@pone.0058027-Sugawara1] to stably express homogenous populations of mammalian IP~3~R subtypes and thereby define structure-activity relationships for AdA and its key analogues for each IP~3~R subtype.

Materials and Methods {#s2}
=====================

Materials {#s2a}
---------

Sources of most reagents were provided in a previous publication [@pone.0058027-Saleem1]. The structures of the ligands used and their abbreviations are shown in [Figure 1A](#pone-0058027-g001){ref-type="fig"}. IP~3~ was from Alexis Biochemicals (Nottingham, UK). AdA [@pone.0058027-Marwood1], imidophostin [@pone.0058027-Marwood2], ribophostin [@pone.0058027-Jenkins1], furanophostin [@pone.0058027-Marwood3], *manno*-AdA and *xylo*-AdA [@pone.0058027-Marwood4], 3″-dephospho AdA and 4″-dephospho AdA [@pone.0058027-Sureshan1], and 2′-dephospho AdA were synthesized, purified and characterized as previously described.

Measurement Ca^2+^ Release by IP~3~ Receptors {#s2b}
---------------------------------------------

From quantitative analyses of western blots using antisera that selectively recognise each IP~3~R subtype or react equally with all three subtypes, we established that in the DT40 cells used, levels of IP~3~R expression (relative to IP~3~R3) were IP~3~R1 (71±8%, n = 3), IP~3~R2 (48±5%) and IP~3~R3 (100%) [@pone.0058027-Saleem1]. It is impracticable to achieve identical levels of IP~3~R expression for each cell line, and differences (albeit modest in our cell lines) may affect both the size of the IP~3~-sensitive Ca^2+^ pool and its sensitivity to IP~3~ [@pone.0058027-Yamazaki1]. The different levels of IP~3~R expression do not compromise the analyses reported here, which are entirely concerned with relative potencies of AdA analogues for each IP~3~R subtype (see below).

A comprehensive description of the methods used to measure free \[Ca^2+^\] within the endoplasmic reticulum of permeabilized DT40 cells was provided in preceding publications [@pone.0058027-Saleem1], [@pone.0058027-Tovey1]. Briefly, the endoplasmic reticulum of DT40 cells stably expressing each of the three mammalian IP~3~R subtypes was loaded with a low-affinity Ca^2+^ indicator (Mag fluo-4) [@pone.0058027-Tovey1]. After permeabilization of the plasma membrane with saponin (10 µg/mL, ∼4 min, 37°C), the permeabilized cells in cytosol-like medium (CLM) were distributed into 96-well plates at 20°C. Addition of MgATP (1.5 mM) then allowed active Ca^2+^ accumulation, which was monitored at intervals of ∼1 s using a FlexStation 3 fluorescence plate-reader (MDS Analytical Devices). CLM had the following composition: 140 mM KCl, 20 mM NaCl, 1 mM EGTA, 20 mM Pipes, pH 7, free \[Ca^2+^\] ∼220 nM (after addition of MgATP), and carbonyl cyanide 4-trifluoromethoxy-phenyl hydrazone (FCCP, 10 µM) to inhibit mitochondrial Ca^2+^ uptake. After 150 s, when the stores had loaded to steady-state with Ca^2+^, IP~3~, AdA or its analogues was added with thapsigargin (1 µM) to prevent further Ca^2+^ uptake, and after a further 30 s, the response was recorded. Agonist-evoked Ca^2+^ release was expressed as a fraction of that released by ionomycin (1 µM) [@pone.0058027-Tovey1]. All experiments were performed at 20°C.

Statistical Analysis {#s2c}
--------------------

Concentration-effect relationships were fitted to Hill equations using GraphPad Prism (version 5.0) from which Hill coefficients (h), the fraction of the intracellular Ca^2+^ stores released by maximally effective concentrations of agonist, and pEC~50~ values (-log EC~50~) were calculated. For convenience some results are presented as EC~50~ values, but all statistical comparisons use pEC~50~ values. Within each experiment, the pEC~50~ for AdA was determined to allow paired comparisons with values obtained for each AdA analogue. These are reported as ΔpEC~50~, where:

We note that [Table 1](#pone-0058027-t001){ref-type="table"} reports pooled results from experiments collected over a considerable period, whereas ΔpEC~50~ values, like those shown in [Table 2](#pone-0058027-t002){ref-type="table"}, compare only paired values. The latter provide the most robust means of comparing agonist potencies. Results are expressed as means ± SEM from n independent experiments, with each experiment performed in triplicate.

10.1371/journal.pone.0058027.t001

###### Effects of AdA analogues on Ca^2+^ release by subtypes of IP~3~ receptor.

![](pone.0058027.t001){#pone-0058027-t001-1}

                                                                      IP~3~R1                                    IP~3~R2                                    IP~3~R3                                                                                                                                                                                                                                                                                                                                                                                                                  
  -------------------------------------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------ -------------------------------------- ---- ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------- ---- ------------------------------------------ ------------------------------------------ ------------------------------------------ ------------------------------------- ----
  (1,4,5)IP~3~                                                           87                                     7.06±0.05                                  0.99±0.05                                   75±1                   31                     145                                     6.84±0.06                                  1.29±0.09                                  61±2                   34                     417                                     6.38±0.05                                  1.26±0.07                                  64±2                   30
  AdA                                                                   8.3                                     8.08±0.09                                  1.17±0.09                                   72±3                   10                     18.2                                    7.74±0.06                                  1.79±0.21                                  56±2                   13                      33                                     7.48±0.09                                  1.13±0.07                                  61±2                   14
  Imidophostin                                                           37                                     7.43±0.28                                  1.17±0.21                                   78±5                   3                       68                                     7.17±0.14                                  1.84±0.50                                  59±3                   3                      166                                     6.78±0.16                                  1.73±0.39                                  67±7                   3
  Ribophostin                                                            40                                     7.40±0.29                                  1.34±0.16                                   77±4                   3                      102                                     6.99±0.11                                  1.60±0.50                                  61±2                   3                      295                                     6.53±0.21                                  1.42±0.08                                  68±4                   3
  Furanophostin                                                          51                                     7.29±0.25                                  0.90±0.10                                   79±6                   3                       76                                     7.12±0.01                                  1.73±0.20                                  60±3                   3                      457                                     6.34±0.18                                  1.27±0.21                                  71±3                   3
  *Manno*-AdA                                                            34                                     7.47±0.19                                  1.33±0.30                                   75±7                   3                       69                                     7.16±0.07                                  1.33±0.22                                  57±3                   3                      245                                     6.61±0.23                                  1.23±0.15                                  69±4                   3
  *Xylo*-AdA                                                            5.9                                     8.23±0.17                                  1.27±0.27                                   73±7                   3                      7.9                                     8.10±0.10                                  1.52±0.40                                  52±6                   3                       29                                     7.54±0.12                                  1.58±0.29                                  64±9                   3
  2′-dephospho-AdA                                                      275                                     6.56±0.13                                  1.31±0.15                                   66±7                   3                      575                                     6.24±0.10                                  0.85±0.07                                  63±2                   3                      692                                     6.16±0.03                                   1.5±0.22                                  55±7                   4
  3″-dephospho-AdA[c](#nt104){ref-type="table-fn"}                       ND                                         ND                                         ND                      15±6[b](#nt103){ref-type="table-fn"}   7                       ND                                         ND                                         ND                      6±2[b](#nt103){ref-type="table-fn"}   6                       ND                                         ND                                         ND                      7±7[b](#nt103){ref-type="table-fn"}   5
  4″-dephospho-AdA                                    Inactive[a](#nt102){ref-type="table-fn"}   Inactive[a](#nt102){ref-type="table-fn"}   Inactive[a](#nt102){ref-type="table-fn"}                    ND                    6    Inactive[a](#nt102){ref-type="table-fn"}   Inactive[a](#nt102){ref-type="table-fn"}   Inactive[a](#nt102){ref-type="table-fn"}                   ND                    6    Inactive[a](#nt102){ref-type="table-fn"}   Inactive[a](#nt102){ref-type="table-fn"}   Inactive[a](#nt102){ref-type="table-fn"}                   ND                    5

The EC~50~ (nM), pEC~50~ (/M), Hill coefficient (h) and fraction (%) of the intracellular Ca^2+^ stores released by a maximally effective concentration of each analogue are shown for each IP~3~R subtype. All results (except EC~50~) are shown as means ± SEM from n independent experiments.

Inactive at 300 µM.

Ca^2+^ release evoked by 300 µM 3″-dephospho AdA.

Refer to [Table 2](#pone-0058027-t002){ref-type="table"} for relative potencies of 3″-dephospho AdA. ND, not determined.

10.1371/journal.pone.0058027.t002

###### Relative potencies of AdA analogues at different IP~3~ receptor subtypes.

![](pone.0058027.t002){#pone-0058027-t002-2}

                          IP~3~R1      IP~3~R2     IP~3~R3
  --------------------- ------------ ----------- -----------
  IP~3~                  1.02±0.02    0.9±0.30    1.1±0.30
  Imidophostin           0.78±0.15    0.78±0.08   0.81±0.04
  Ribophostin            0.82±0.18    0.96±0.20   1.06±0.07
  Furanophostin          0.92±0.13    0.83±0.14   1.25±0.05
  *Manno*-AdA            0.74±0.08    0.79±0.18   0.98±0.08
  *Xylo*-AdA             −0.01±0.07   −0.3±0.27   0.05±0.08
  2′-dephospho-AdA       1.24±0.33    1.60±0.18   1.68±0.16
  3″-dephospho-AdA^a^    4.03±0.09    4.47±0.30   4.13±0.14

From paired comparisons with AdA, the potency (ΔpEC~50~) of the analogues relative to AdA is shown for each IP~3~R subtype. Results are means ± SEM, with n provided in [Table 1](#pone-0058027-t001){ref-type="table"}. ND, not determined. ^a^Because the very low affinity of 3″-dephospho AdA for IP~3~R made it impracticable to stimulate cells with a maximally effective concentration, 'ΔpEC~50~' for 3″-dephospho AdA was estimated by comparing concentrations of it and AdA that evoked the same sub-maximal Ca^2+^ release.

Statistical comparisons used Student's t-test or ANOVA followed by Bonferroni's *post hoc* test, as appropriate, with *P*\<0.05 considered significant. Because not all comparisons of the relative potencies of AdA and IP~3~ were paired, the SEM of this ΔpEC~50~ value was calculated from:where, s~p~ is the estimate of the population variance:

where, s~1~ and s~2~ are the sample standard deviations, and n~1~ and n~2~ are the sample sizes [@pone.0058027-Ott1].

Results {#s3}
=======

Quantal Ca^2+^ Release Evoked by AdA and IP~3~ {#s3a}
----------------------------------------------

The kinetics of IP~3~-evoked Ca^2+^ release from intracellular stores are unexpectedly complex. It is widely observed that under conditions where Ca^2+^ uptake into the endoplasmic reticulum (ER) is inhibited, submaximally effective concentrations of IP~3~ rapidly release only a fraction of the IP~3~-sensitive Ca^2+^ stores [@pone.0058027-Taylor4]. Thereafter, there is either no, or a massively reduced, effect of IP~3~ on the rate of Ca^2+^ release. The mechanisms underlying this pattern of response, known as quantal Ca^2+^ release [@pone.0058027-Muallem1], remain unclear. It may require desensitization of IP~3~R as the Ca^2+^ content of the ER declines [@pone.0058027-Irvine1] or heterogeneity among IP~3~-senstive Ca^2+^ stores [@pone.0058027-Hirose1]. The results shown in [Figures 1B and C](#pone-0058027-g001){ref-type="fig"} confirm that the Ca^2+^ release evoked by submaximal concentrations of either IP~3~ or AdA from permeabilized DT40-IP~3~R1 cells is quantal. These observations provide the justification for all subsequent experiments in which the concentration-dependent effects of IP~3~ or AdA were measured 30 s after their addition (see [Methods](#s2){ref-type="sec"}).

AdA is a Potent Agonist of All Three IP~3~ Receptor Subtypes {#s3b}
------------------------------------------------------------

The results shown in [Figure 2](#pone-0058027-g002){ref-type="fig"} and [Tables 1](#pone-0058027-t001){ref-type="table"} and [2](#pone-0058027-t002){ref-type="table"} demonstrate that AdA is ∼10-times more potent than IP~3~ at each IP~3~R subtype, and for each subtype, maximally effective concentrations of IP~3~ and AdA release the same fraction of the intracellular Ca^2+^ stores. This is consistent with many analyses of IP~3~ and AdA in a variety of cell types using both functional and binding assays, in which AdA behaves as a full agonist with ∼10-fold greater affinity than IP~3~ \[reviewed in 8\]. Our results do, however, provide the first direct demonstration that AdA interacts similarly with all three IP~3~R subtypes. Subsequent experiments examine the interactions between key analogues of IP~3~ and AdA with each IP~3~R subtype.

![AdA is a potent agonist of all three IP~3~ receptor subtypes.\
(A) Concentration-dependent effects of AdA on Ca^2+^ release from the intracellular stores of cells expressing IP~3~R1, IP~3~R2 or IP~3~R3. All results are expressed as percentages of the Ca^2+^ release evoked by ionomycin. The same colour codes are used in all subsequent figures. (B) Comparison, for each IP~3~R subtype, of the Ca^2+^ release evoked by IP~3~ and AdA. Results are means ± SEM from the number of independent experiments given in [Table 1](#pone-0058027-t001){ref-type="table"}. Here, and in many subsequent figures, some error bars are smaller than the symbols.](pone.0058027.g002){#pone-0058027-g002}

Trimming the Adenosine Moiety of AdA Reduces its Potency at All IP~3~ Receptor Subtypes {#s3c}
---------------------------------------------------------------------------------------

Systematic trimming of the adenosine moiety of AdA successively produces imidophostin (which lacks the pyrimidine ring of AdA), ribophostin (in which a methoxy group replaces the adenine moiety of AdA) and furanophostin (in which only the furanoid ring remains) ([Figure 1A](#pone-0058027-g001){ref-type="fig"}). Maximally effective concentrations of each of these analogues released the same fraction of the intracellular Ca^2+^ stores as AdA in cells expressing each of the three IP~3~R subtypes, and each analogue was ∼5-10-fold less potent than AdA ([Figure 3](#pone-0058027-g003){ref-type="fig"}, [Tables 1](#pone-0058027-t001){ref-type="table"} and [2](#pone-0058027-t002){ref-type="table"}). These results are consistent with previous analyses of IP~3~R in hepatocytes, which express predominantly IP~3~R2 [@pone.0058027-Marwood2], [@pone.0058027-Correa1], with analyses of binding of ribophostin and furanophostin to an N-terminal fragment of IP~3~R1 [@pone.0058027-Rossi2], and with evidence from other analogues that trimming the adenosine moiety decreases affinity for cerebellar IP~3~R, which are largely IP~3~R1 [@pone.0058027-Shuto1].

![Trimming the adenosine moiety of AdA reduces potency.\
(A--F) Effects of imidophostin (A), ribophostin (C) and furanophostin (E) on Ca^2+^ release via each of the three IP~3~R subtypes, and the same analogues compared with AdA (B, D and F). Results are means ± S.E.M. from 3 independent experiments. (G) A cation-π interaction between the adenine of AdA and R504 within the α-domain of the IBC is proposed to stabilize AdA binding (left). Closure of the clam-like IBC is proposed to be mediated by interactions between the 3″-phosphate of AdA and the α-domain of the IBC (blue ribbon), and between the 4″-phosphate and the β-domain of the IBC (green ribbon). In 3″-dephospho AdA, a cation-π interaction between AdA and the IBC α-domain is proposed to be sufficient to allow some effective closure of the clam. R504 is conserved in all three mammalian IP~3~R subtypes (right).](pone.0058027.g003){#pone-0058027-g003}

These results are consistent with our earlier conclusion that the 10-fold greater affinity of AdA relative to IP~3~ requires the adenine moiety of AdA positioned to allow it to form a cation-π interaction with Arg-504 in the α-domain of the IBC of IP~3~R1, a residue that is conserved in all IP~3~R subtypes [@pone.0058027-Rossi1], [@pone.0058027-Rossi2] ([Figure 3G](#pone-0058027-g003){ref-type="fig"}). We suggest that this interaction of AdA with IP~3~R is likely to be similar for all IP~3~R subtypes.

Hydroxyl Moieties that are Important for IP~3~ Binding are Less Important for Binding of AdA {#s3d}
--------------------------------------------------------------------------------------------

The 5″-CH~2~OH and 2″-OH substituents of the glucose ring of AdA are thought to mimic the 3-OH and 6-OH of IP~3~, respectively ([Figure 1A](#pone-0058027-g001){ref-type="fig"}). A structure equivalent to the 6-OH of IP~3~ is an essential feature of all inositol phosphate analogues that bind to IP~3~R [@pone.0058027-Wilcox1], [@pone.0058027-Polokoff1], [@pone.0058027-Safrany1] and inversion of its orientation from equatorial to axial reduces affinity by more than 100-fold at all IP~3~R subtypes [@pone.0058027-Nerou1]. It is therefore surprising, but consistent with previous analyses of native hepatic IP~3~R [@pone.0058027-Correa1], that *manno*-AdA, which differs from AdA only in the orientation of its 2″-OH, should be only 5- to 10-fold less potent than AdA at each IP~3~R subtype ([Figures 4A and B](#pone-0058027-g004){ref-type="fig"}, [Tables 1](#pone-0058027-t001){ref-type="table"} and [2](#pone-0058027-t002){ref-type="table"}). Why, when the 6-OH of IP~3~ and 2″-OH of AdA seem to be analogous in the ligand structures, should these moieties make such different contributions to the interactions of IP~3~ and AdA with IP~3~R?

![Hydroxyl groups within the glucose ring of AdA are unimportant.\
(A--D) Effects of *manno*-AdA (A) and *xylo*-AdA (C) on Ca^2+^ release via each IP~3~R subtype, and the same analogues compared with AdA (B and D). Results are means ± S.E.M. from 3 independent experiments.](pone.0058027.g004){#pone-0058027-g004}

The 6-OH of IP~3~ interacts, through a water molecule, with a lysine residue (K569) in the IBC [@pone.0058027-Bosanac1] and, by interacting with the adjacent 1-phosphate, it has also been proposed to influence the behaviour of the 4,5-bisphosphate moiety of IP~3~ [@pone.0058027-Felemez1]. The latter interaction is unlikely to contribute to AdA binding because the structures equivalent to the 6-OH (2″-OH of AdA) and the 1-phosphate of IP~3~ (2′-phosphate of AdA) are in different rings in AdA ([Figure 1A](#pone-0058027-g001){ref-type="fig"}). We suggest that the lesser importance in AdA of a structure equivalent to the essential 6-OH of IP~3~ comes from this hydroxyl mediating a relatively minor interaction with K569 in AdA, whereas for IP~3~ it contributes also to appropriately orienting the critical 4,5-bisphosphate moiety.

The 3-OH group, although less important than the 6-OH, is another feature of IP~3~ that contributes to high-affinity binding [@pone.0058027-Wilcox2]. Our recent analyses of the functional effects of 3-deoxy-IP~3~ established that it was ∼40-fold less potent than IP~3~ at all three IP~3~R subtypes [@pone.0058027-Saleem1]. This is consistent with earlier work showing that 3-deoxy-IP~3~ and analogues with other modifications of the 3-position have reduced affinity for the three IP~3~R subtypes [@pone.0058027-Nerou1]. However, the equivalent modification of AdA, removal of its 5″-CH~2~OH to give *xylo*-AdA ([Figure 1A](#pone-0058027-g001){ref-type="fig"}), had no significant effect on its potency at any IP~3~R subtype ([Figures 4C and D](#pone-0058027-g004){ref-type="fig"}, [Tables 1](#pone-0058027-t001){ref-type="table"} and [2](#pone-0058027-t002){ref-type="table"}). This is consistent with a previous functional analysis of hepatic IP~3~R, where *xylo*-AdA was only marginally less potent than AdA (ΔpEC~50~ ∼0.28) [@pone.0058027-Correa1]. Our results suggest that despite the apparent structural similarity between the 3-OH of IP~3~ and the 5″-CH~2~OH of AdA ([Figure 1A](#pone-0058027-g001){ref-type="fig"}), the two hydroxyl groups do not contribute similarly to ligand binding. Previous analyses of IP~3~ analogues suggested that replacing the 3-OH with the larger CH~2~OH moiety caused the affinity to decrease by no more than 7-fold [@pone.0058027-Nerou1]. A partial explanation for the lack of effect of removing the 5″-CH~2~OH of AdA may therefore be that this moiety is less readily accommodated than a hydroxyl group in the IBC. This would suggest that an analogue of AdA in which the 5″-CH~2~OH is replaced by 5″-OH might bind with increased affinity. We are unaware of such an analogue having been synthesized. The larger substituent at the 5″-position of AdA is, however, unlikely to provide the sole explanation for it making no discernible contribution to binding.

The 2′-phosphate of AdA is not a Super-optimal Mimic of the 1-phosphate of IP~3~ {#s3e}
--------------------------------------------------------------------------------

It has been suggested that the 2′-phosphate of AdA interacts with the IBC in a manner that allows it to behave as a super-optimal mimic of the 1-phosphate of IP~3~ [@pone.0058027-Takahashi3], [@pone.0058027-Hotoda2]. However, our recent study combining structure-activity analyses with mutagenesis of the binding site suggest that the 1-phosphate of IP~3~ is more important for binding than is the 2′-phosphate of AdA [@pone.0058027-Rossi2]. Removal of the 1-phosphate from IP~3~ (to give (4,5)IP~2~) caused its potency and affinity for IP~3~R1 to decrease by ∼100-fold [@pone.0058027-Rossi2], whereas removal of the 2′-phosphate from AdA (2′-dephospho AdA) causes a decrease in potency of ∼17-fold in IP~3~R1 ([Figure 5](#pone-0058027-g005){ref-type="fig"}) and ∼40-fold decreases in potency were obtained with 2′-dephospho AdA and IP~3~R2 and IP~3~R3 ([Figure 5](#pone-0058027-g005){ref-type="fig"}, [Table 1](#pone-0058027-t001){ref-type="table"} and [2](#pone-0058027-t002){ref-type="table"}). These results establish that for all three IP~3~R subtypes, the enhanced affinity of AdA is not due to its 2′-phosphate interacting more effectively than the 1-phosphate of IP~3~ with the IBC.

![The 2*′*-phosphate of AdA is not the primary cause of its increased potency.\
(A) Effects of 2*′*-dephospho AdA on Ca^2+^ release via each IP~3~R subtype. (B) The same analogue compared with AdA. Results are means ± S.E.M. from 3--4 independent experiments.](pone.0058027.g005){#pone-0058027-g005}

A Bisphosphate Moiety is not Essential for Activation of IP~3~ Receptors by AdA {#s3f}
-------------------------------------------------------------------------------

All known active analogues of IP~3~ have structures equivalent to its 4,5-bisphosphate moiety [@pone.0058027-Wilcox1]. Structures of the IBC with and without IP~3~ bound provide a rationale for this requirement by revealing that these two phosphate groups contact opposite sides (the α- and β-domains) of the clam-like IBC, closure of which initiates IP~3~R activation [@pone.0058027-Seo1], [@pone.0058027-Bosanac1]. Substantial evidence suggests that the 4″,3″-bisphosphate moiety of AdA mimics the critical 4,5-bisphosphate of IP~3~ [@pone.0058027-Rossi1] ([Figure 1A](#pone-0058027-g001){ref-type="fig"}).

4″-dephospho-AdA at concentrations up to 300 µM failed to evoke Ca^2+^ release via any IP~3~R subtype ([Figure 6A](#pone-0058027-g006){ref-type="fig"}). This is consistent with previous analyses by both functional and binding assays of IP~3~R1 [@pone.0058027-Sureshan1], [@pone.0058027-Sureshan2]. 3″-dephospho-AdA did, however, cause detectable Ca^2+^ release albeit with much reduced potency ([Figure 6B](#pone-0058027-g006){ref-type="fig"}). The synthetic route used to prepare 3″-dephospho-AdA makes it extremely unlikely that the activity could be due to minor contamination with AdA or related structures with a vicinal bisphosphate moiety. Maximal attainable concentrations of 3″-dephospho-AdA (300 µM) failed to release the entire IP~3~-sensitive Ca^2+^ store, but comparison of the concentrations required to achieve the same submaximal Ca^2+^ release suggests that 3″-dephospho-AdA is ∼10,000-fold less potent than AdA at all three IP~3~R subtypes. With such a massive reduction in potency the lesser sensitivity of DT40-IP~3~R3 cells to AdA means that even the highest practicable concentration of 3″-dephospho-AdA (300 µM) is close to the threshold for detecting Ca^2+^ release ([Figure 6B](#pone-0058027-g006){ref-type="fig"}).

![Structures equivalent to the 4,5-bisphosphate of IP~3~ are not essential for AdA activity.\
(A, B) Concentration-dependent effects on Ca^2+^ release via each IP~3~R subtype of 4″-dephospho AdA (A) and 3″-dephospho AdA (B) compared with AdA. Results are means ± SEM from n independent experiments (n is provided in [Table 1](#pone-0058027-t001){ref-type="table"}). (C) Concentration-dependent effects of IP~3~ alone on Ca^2+^ release via IP~3~R1 or after pre-incubation (30 s) with 3″-dephospho AdA (30 µM), which itself evoked release of 21±5% of the intracellular Ca^2+^ stores. Results (C) are means ± SEM from 3 independent experiments.](pone.0058027.g006){#pone-0058027-g006}

The inability of high concentrations of 3″-dephospho-AdA to release the entire IP~3~-sensitive Ca^2+^ store is likely to be due solely to its reduced affinity rather than reduced efficacy. A concentration of 3″-dephospho-AdA (30 µM) that caused detectable Ca^2+^ release via IP~3~R1 (∼21±5%) had no effect on the sensitivity of the Ca^2+^ release evoked by a subsequent addition of IP~3~. The pEC~50~ was 7.00±0.02 and 7.04±0.06 (n = 3) for (1,4,5)IP~3~ alone and in the presence of 3″-dephospho-AdA, respectively ([Figure 6C](#pone-0058027-g006){ref-type="fig"}). A partial agonist would be expected to shift the sensitivity to higher concentrations of IP~3~. These results suggest that 3″-dephospho-AdA is a low-affinity full agonist of IP~3~R.

These results extend our previous analyses of IP~3~R1 by demonstrating that for all IP~3~R subtypes, the 4″-phosphate group of AdA is essential for activity, whereas the 3″-phosphate is important but not essential. 3″-dephospho-AdA is the only known agonist of IP~3~R to lack a structure equivalent to the 4,5-bisphosphate moiety of IP~3~.

Discussion {#s4}
==========

AdA is a high-affinity full agonist of IP~3~R that has been extensively used to explore the behaviour of IP~3~R \[reviewed in8\]. The activity of AdA has been confirmed in many cell types, but hitherto there has been no assessment of its activity in homogenous populations of IP~3~R subtypes. We have demonstrated that AdA is ∼10-fold more potent than IP~3~R at each IP~3~R subtype ([Figure 2](#pone-0058027-g002){ref-type="fig"}, [Tables 1](#pone-0058027-t001){ref-type="table"} and [2](#pone-0058027-t002){ref-type="table"}), and the structural determinants of its high-affinity interaction with IP~3~R are similar for all three IP~3~R subtypes. Contrary to an earlier suggestion that the 2′-phosphate of AdA mediates its enhanced affinity by forming a stronger interaction with the IBC than the analogous 1-phosphate of IP~3~, we find that the 1-phosphate makes a greater contribution to IP~3~ binding than does the 2′-phosphate of AdA ([Figure 5](#pone-0058027-g005){ref-type="fig"}) [@pone.0058027-Rossi2]. A more likely explanation for the enhanced affinity of AdA is a cation-π interaction between its adenine moiety and R504 within the α-subunit of the IBC ([Figure 3G](#pone-0058027-g003){ref-type="fig"}) [@pone.0058027-Sureshan1]. That explanation is supported by results for each IP~3~R subtype showing that truncation of the adenosine moiety of AdA brings the potency of the resulting analogues (imidophostin, ribophostin and furanophostin) close to that of IP~3~ ([Figure 3](#pone-0058027-g003){ref-type="fig"}).

A key step in the initial activation of IP~3~R by IP~3~ appears to be closure of its clam-like IBC as the 4-phosphate of IP~3~ contacts one side of the clam (its β-domain) and the 5-phosphate contacts the other side (α-domain) [@pone.0058027-Seo1]. That mechanism provides a satisfying explanation for the long-standing observation that all inositol phosphates that activate IP~3~R share this essential 4,5-bisphosphate moiety. AdA is different in that its 4″-phosphate (analogous to the 4-phosphate of IP~3~, [Figure 1A](#pone-0058027-g001){ref-type="fig"}) is essential, but 3″-dephospho-AdA retains activity at all three IP~3~R subtypes, albeit with very low affinity ([Figure 6](#pone-0058027-g006){ref-type="fig"}). We suggest that for AdA, the need for the bisphosphate moiety to cause closure of the IBC can be partially replaced for all IP~3~R subtypes by having an interaction between the adenine of AdA and the α-domain substitute for the interaction between the 3″-phosphate (analogous to the 5-phosphate of IP~3~) and the α-domain [@pone.0058027-Sureshan1]. Finally, whereas the 6-OH and, to a lesser extent, the 3-OH of IP~3~ are important for IP~3~ binding, the equivalent structures within AdA play lesser roles.

Both store-operated Ca^2+^ entry, which is triggered by depletion of IP~3~-sensitive Ca^2+^ stores [@pone.0058027-Putney1], and the spatial organization of subcellular Ca^2+^ signals have been reported to be differentially affected by IP~3~, AdA or its analogues [@pone.0058027-Marchant1], [@pone.0058027-Bird1], [@pone.0058027-DeLisle1], [@pone.0058027-Hartzell1], [@pone.0058027-Machaca1], [@pone.0058027-Parekh1]. Our present results, which demonstrate that AdA structure-activity relationships are similar for all IP~3~R subtypes, suggest that different physiological effects of IP~3~, AdA or its analogues are more likely to result from differences in their affinities, kinetics or rates of degradation than from selective interactions with different IP~3~R subtypes.
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